DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04200755 (ClinicalTrials.gov)	May 19, 2020	10/12/2019	Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma	A Randomized, Placebo-controlled Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Subcutaneous Dupilumab in Localized Scleroderma	Localized Scleroderma	Drug: Dupilumab 300Mg Solution for Injection;Other: Placebo	University of Cologne	NULL	Recruiting	18 Years	N/A	All	45	Phase 2	Germany

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

May 19, 2020

10/12/2019

Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma

A Randomized, Placebo-controlled Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Subcutaneous Dupilumab in Localized Scleroderma

Localized Scleroderma

Drug: Dupilumab 300Mg Solution for Injection;Other: Placebo

University of Cologne

NULL

Recruiting

18 Years

N/A

All

Phase 2

Germany